全部

1·The atorvastatin group found no serious adverse reactions.

阿托伐他汀组未发现严重的不良反应。

2·Carotid artery atherosclerosis; Atorvastatin calcium; Conventional treatment.

颈动脉粥样硬化；阿托伐他汀钙；常规治疗。

3·Conclusion Atorvastatin is similar in curative effect and safety to Xuezhikang.

结论血脂康与阿托伐他汀降脂疗效与安全性相似。

4·CONCLUSION: Atorvastatin can increase ABCA1 mediated intracellular cholesterol efflux.

结论：阿托伐他汀促进ABCA1介导的细胞内胆固醇外流。

5·Conclusions: Atorvastatin may improve heart function of patients with DCM heart failure.

结论：托伐他汀可进一步改善DC M心力衰竭患者的心功能。

6·Objective to study the influence of atorvastatin on the atherosclerosis plaque of carotid artery.

目的研究阿托伐他汀对颈动脉粥样硬化斑块的影响。

7·Objective to study the clinical effect of atorvastatin on arteriosclerosis plaque of carotid artery.

目的探讨阿托伐他汀对颈动脉粥样斑块的临床影响。

8·In this text, we reviewed the effect of atorvastatin on the treatment of cardiac myocyte hypertrophy.

本文从心肌细胞肥大这个角度阐述阿托伐他汀对心室重塑的影响。

9·Treatment with atorvastatin increased the risk of brain hemorrhage by 68 percent, the report indicates.

报告指出，阿托伐他汀治疗能增加68%的脑出血的风险。

10·This paper introduced research status of atorvastatin and to put forward the ideas of drug development.

文中介绍了阿托伐他汀的研究状况，并提出药物开发的思路。